The newsletter
From the desk of Dr. Richard Mann.
Receive Dr. Mann’s insights, updates, and news on benfotiamine, directly to your inbox.
What you’ll get
Three reasons to subscribe.
01
New research.
Recent studies on benfotiamine, briefly summarized.
02
Clinical perspective.
How Dr. Mann reads the science.
03
What it means.
For nerve and brain health, and where the research is going.
Lately
Recent from Dr. Mann.
Nerve Health
September 22, 2026
Duke University Study Describes a Breakthrough in Our Understanding of the Bioenergetics of Peripheral Sensory Nerves
Read moreBrain Health
March 10, 2026
Richard Mann, DPM, Publishes Case Series on Nutritional Approach Using Benfotiamine in Long COVID Brain Fog
Read moreNerve Health
May 21, 2025
Rethinking High-Dose Oral Vitamin B12: Improving Patient Safety in Response to Emerging Data
Read moreFAQ
Common questions
Who is this newsletter for?
Anyone interested in benfotiamine. Patients, caregivers, and clinicians all subscribe. Dr. Mann writes for the informed reader without assuming a clinical background.
What does Dr. Mann write about?
Benfotiamine. New research, clinical insights, and how the compound applies to nerve health, brain health, and related areas.
Will my email be shared or sold?
No. It’s used only for this newsletter.
How do I unsubscribe?
One click in any email.